COCP: Phase 1 Single-Ascending Dose Cohort of CDI-988 Shows it is Safe and Well Tolerated
On July 18, 2024, Cocrystal Pharma, Inc. (COCP) reported favorable safety and tolerability results from the single-ascending dose (SAD) cohorts of...
317 Views
LGVN: Alzheimer's Drug on a Roll with FDA
Longeveron is focusing on using its primary treatment, Lomecel-B, to fight a rare pediatric heart birth defect that devastates families but...
316 Views
TNXP: High Interest in Tonmya Seen in Initial Findings from Market Opportunity Analysis
On May 13, 2024, Tonix Pharmaceuticals Holding Corp. (TNXP) announced financial results for the first quarter of 2024 and provided a business...
186 Views
Medicus Pharma Ltd. - Medicus Submits Updated Phase 2 Clinical Protocol
Management plans fast-track these specific therapies through FDA clinical trials toward commercialization. The company's first acquisition was SkinJec
145 Views
LGVN: Alzheimer's Drug on a Roll with FDA
Longeveron is focusing on using its primary treatment, Lomecel-B, to fight a rare pediatric heart birth defect that devastates families but...
146 Views